Focus Area
Oncology
Integrated oncology strategy and medical communications to build credibility, sharpen differentiation, and execute consistently across launch.
Client overview
An emerging biopharmaceutical company was preparing for its first global launch of a late-stage specialty therapy with limited internal bandwidth to support a multi-indication launch journey.
Business challenge
- Establish credibility and differentiation in a crowded oncology category while building the company and the asset story in parallel
- Maintain a consistent core narrative that flexes across indications, data readouts, and launch waves over multiple years
- Execute high-quality medical and stakeholder communications at pace with lean internal teams and intense competitive pressure
Our approach
Our strategy-led AOR model embedded oncology strategy within medical communications to keep positioning, evidence storytelling, and execution aligned across indications and milestones.
Valued outcomes
- Strategic consistency: A durable core narrative that scales across indications and evolving data
- Differentiation: Clear positioning supported by competitive mapping and scenario planning
- Scaled delivery: Reliable, high-quality communications output through an AOR operating cadence
- Credibility building: More confident, better-informed engagement with external experts and stakeholders
